PR Newswire Clinical TrialsOriginal article
Nyra Medical Announces First Patient Enrollment in ENHANCE Early Feasibility Study, Advancing Next Generation Mitral Valve Repair Platform
Trial StartCARLEN™ SystemPositive
AI Analysis
Summary
Nyra Medical announced first patient enrollment in the ENHANCE Early Feasibility Study for its CARLEN™ System, a next-generation mitral valve repair platform. The clinical program is expanding to the United States and Brazil following successful first-in-human experience.
Clinical Trial Data
Phase
Early Feasibility
Outcome Details
First patient enrollment in ENHANCE Early Feasibility Study
Importance:5/10
Sentiment:
0.70
clinical trialmedical devicemitral valve repairearly feasibility studyfirst patient enrollment
Read the original article
Published by PR Newswire Clinical Trials on July 7, 2026 2:05 PM